REMS: What It’s All About
The Carlat Addiction Treatment Report, Volume 2, Number 7, November 2014
https://www.thecarlatreport.com/newsletter-issue/catrv2n7/
Issue Links: Learning Objectives | Editorial Information
Topics: Practice Tools and Tips
Find out what the FDA’s Risk Evaluation and Mitigation Strategies (REMS) program focusing on extended-release and long-acting opioid analgesic medications is all about, in an interview with Edwin A. Salsitz, MD.
You can't view details of this content, please login or buy subscription here